Only a handful of studies have focused on Ig-CAMs, including one pertaining to Necl in lung adenocarcinoma, where ST6Gal1 was identified as a target of mir-199a leading to reduction of Necl-2 sialylation (Minami et al., 2013). This evidence concerns the gene ST6GAL1 and lung adenocarcinoma.